Lugano, Switzerland - February 18th, 2026 - Helsinn Healthcare SA ('Helsinn”), a global pharmaceutical group focused on supporting patients with cancer and chronic diseases, today announced that the ...
5m
Helsinn Healthcare S.A.: Helsinn announces European Commission approval of AKYNZEO Oral Suspension
Lugano, Switzerland - February 18th, 2026 - Helsinn Healthcare SA ("Helsinn"), a global pharmaceutical group focused on supporting patients with cancer and chronic diseases, today announced that the E ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results